Is oral cancer unique in terms of chemotherapeutic and targeted drug metabolism?

J Oral Maxillofac Surg. 2015 Jan;73(1):4-6. doi: 10.1016/j.joms.2014.09.017.

Authors

Sachin C Sarode¹, Gargi S Sarode²

Affiliations

¹ Professor, Department of Oral Pathology and Microbiology, Dr. D. Y. Patil Dental College and Hospital, Pimpri, India. Electronic address: [email protected].
² Associate Professor, Department of Oral Pathology and Microbiology, Dr. D. Y. Patil Dental College and Hospital, Pimpri, India.

PMID: 25511953
DOI: 10.1016/j.joms.2014.09.017

No abstract available

MeSH terms

Antineoplastic Agents / metabolism
Antineoplastic Agents / therapeutic use*
C-Reactive Protein / immunology
Carcinoma, Squamous Cell / drug therapy
Carcinoma, Squamous Cell / metabolism
Chemoradiotherapy, Adjuvant / methods
Cytochrome P-450 CYP3A / metabolism
Cytokines / immunology
Humans
Inflammation Mediators / immunology
Molecular Targeted Therapy / methods*
Mouth / immunology
Mouth / metabolism
Mouth / microbiology
Mouth Neoplasms / drug therapy*
Mouth Neoplasms / metabolism
Precancerous Conditions / immunology
Precancerous Conditions / metabolism
Risk Assessment
Risk Factors

Substances

Antineoplastic Agents
Cytokines
Inflammation Mediators
C-Reactive Protein
Cytochrome P-450 CYP3A
CYP3A4 protein, human